First in Human Study of AZD9592 in Solid Tumors

Clinical trial NCT05647122 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05647122
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumours Carcinoma Non-small Cell Lung Head and Neck Neoplasms Colorectal Neoplasms

Start date: 2022-12-21
Primary completion: 2028-08-03
Enrollment: 167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.